Scarica l'app Stockscreener
12.08
4.20%
-0.53
Dopo l'orario di chiusura:
12.80
0.72
+5.96%
Polyrizon Ltd Borsa (PLRZ) Ultime notizie
Technical Analysis: Can Polyrizon Ltd weather a recession2026 Support & Resistance & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Aug Volume: Can Polyrizon Ltd weather a recessionCEO Change & Intraday High Probability Setup Alerts - baoquankhu1.vn
PLRZ Should I Buy - Intellectia AI
PLRZ.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PLRZ News & Events - Intellectia AI
PLRZ.O Technical Analysis & Stock Price Forecast - Intellectia AI
Insider Sell: CEO Tomer Izraeli Sells 500 Shares of Polyrizon Lt - GuruFocus
Polyrizon (PLRZ) CEO sells 500 shares in open-market trade - Stock Titan
Carmel Liron of Polyrizon (PLRZ) sells 942 shares, holds 3,127 - Stock Titan
Polyrizon (PLRZ) director sells 3,292 shares, retains 19,850 total - Stock Titan
Patterns Watch: Can Polyrizon Ltd beat the S P 500Entry Point & Expert Curated Trade Ideas - baoquankhu1.vn
Levels Update: Will Polyrizon Ltd outperform its industry peers2026 Opening Moves & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Top Polyrizon Insiders Quietly Cash Out in Notable Stock Moves - TipRanks
Insiders Make Big Moves at Polyrizon as Directors Cash Out Company Stock - tipranks.com
Director at Polyrizon (PLRZ) sells 100 shares, retains 4,069 - Stock Titan
Polyrizon (PLRZ) CEO sells 3,900 shares, holding 32,012 afterward - Stock Titan
Polyrizon (PLRZ) CTO trims stake with 2,917-share open-market sale - Stock Titan
VIX Spike: Can Polyrizon Ltd disrupt its industryGDP Growth & Growth Focused Entry Reports - baoquankhu1.vn
We're Keeping An Eye On Polyrizon's (NASDAQ:PLRZ) Cash Burn Rate - simplywall.st
US Market Wrap: Will Polyrizon Ltd outperform its industry peersWeekly Trend Recap & Risk Managed Investment Signals - baoquankhu1.vn
Polyrizon (PLRZ) updates 20-F, outlines $464,000 cyber fraud response - Stock Titan
Polyrizon reports $17.5M cash position, advances FDA discussions By Investing.com - Investing.com South Africa
Polyrizon reports $17.5M cash position, advances FDA discussions - Investing.com
Polyrizon Provides 2025 and Recent Highlights - The Manila Times
Polyrizon pushes allergy and viral nasal blockers toward U.S. trials - Stock Titan
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025 - The Manila Times
Polyrizon (PLRZ) 20-F: deepening losses, cash position and high biotech risks - Stock Titan
Polyrizon signs MOU to acquire 20% stake in drone maker Colugo - Investing.com Australia
Polyrizon signs MOU to acquire up to 20% stake in eVTOL firm Colugo - MSN
Polyrizon Intends to Acquire up to 20% Stake in Colugo, Developer of Advanced eVTOL Drones for Defense and Urban Air Mobility Applications - The Manila Times
Why a nasal drug developer wants a stake in an Israeli eVTOL drone maker - Stock Titan
Polyrizon Ltd. signing of a non-binding Memorandum of Understanding to acquire 20% stake in Colugo Systems Ltd. from two shareholders of for $6 million. - MarketScreener
Insider Sell: Does Polyrizon Ltd offer margin of safety2026 Valuation Update & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Market Trends: Will Polyrizon Ltd stock hit new highs in YEAR2026 Buyback Activity & Stepwise Trade Execution Plans - baoquankhu1.vn
Polyrizon (PLRZ) CTO details initial share and option holdings - Stock Titan
[Form 3] Polyrizon Ltd. Initial Statement of Beneficial Ownership - Stock Titan
Polyrizon (PLRZ) Chief Science Officer reports share and option holdings - Stock Titan
Director Itzhaik Asaf details restricted share holdings at Polyrizon (PLRZ) - Stock Titan
Polyrizon (PLRZ) director discloses initial restricted share holdings - Stock Titan
Polyrizon (PLRZ) director discloses vested and restricted share holdings - Stock Titan
Carmel Liron details Polyrizon (PLRZ) restricted share ownership and vesting - Stock Titan
Polyrizon (PLRZ) CEO Tomer Izraeli details initial share and option holdings - Stock Titan
Polyrizon (PLRZ) CFO details initial share and option holdings - Stock Titan
Tomer Izraeli Net Worth (2026) - GuruFocus
Polyrizon signs CRO agreement for biocompatibility studies By Investing.com - in.investing.com
Polyrizon signs CRO agreement for biocompatibility studies - Investing.com
Polyrizon Taps Global CRO to Run Key Preclinical Safety Studies Ahead of First Clinical Trials - TipRanks
Polyrizon Signs an Agreement with Leading Global Preclinical CRO as Part of Clinical Development Program - The Manila Times
Polyrizon (PLRZ) signs global CRO pact to advance nasal hydrogel trials - Stock Titan
Nasal allergy startup Polyrizon readies human trials with safety tests - Stock Titan
Eli Zamir reports ≤5% stake in Polyrizon Ltd. (PLRZ) via Schedule 13G - Stock Titan
Polyrizon (PLRZ) Institutional Ownership 2026 - MarketBeat
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):